Roivant Sciences (ROIV) Long-Term Investments (2021 - 2025)

Roivant Sciences (ROIV) has reported Long-Term Investments for 4 consecutive years, with $163.8 million the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Long-Term Investments rose 14.58% year-over-year to $163.8 million; the trailing twelve-month figure through Jun 2025 stood at $163.8 million (up 14.58% YoY), and the FY2025 full-year result was $167.4 million, up 13.45% from the prior year.
• Long-Term Investments slipped to $163.8 million in Q2 2025 per ROIV's latest filing, from $167.4 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $178.6 million in Q1 2023 and bottomed at $100.6 million in Q1 2021.
• Historically, Long-Term Investments has averaged $147.9 million across 4 years, with a median of $161.8 million in 2024.
• The widest YoY moves for Long-Term Investments: up 19.92% in 2024, down 17.39% in 2024.
• Over 4 years, Long-Term Investments stood at $100.6 million in 2021, then soared by 35.17% to $135.9 million in 2023, then advanced by 19.92% to $163.0 million in 2024, then climbed by 0.47% to $163.8 million in 2025.
• According to Business Quant data, Long-Term Investments over the past three periods registered $163.8 million, $167.4 million, and $163.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.